Medytox protests US trade board ruling in favor of Hugel
Medytox, Korea’s first botulinum toxin developer, has voiced its objections to the United States International Trade Commission’s (USITC) recent decision to acquit Hugel, another Korean medical aesthetics company, of stealing Medytox’s botulinum toxin strains.
Oct 11, 2024By Park Jae-hyuk